America First Multifamily Investors, L.P. Reports Second Quarter 2017 Earnings
Aug 07, 2017 12:00 pm UTC| Business
OMAHA, Neb., Aug. 07, 2017 -- On August 7, 2017, America First Multifamily Investors, L.P. (NASDAQ:ATAX) (the “Partnership”) reported the following operating results: For the quarter ended June 30, 2017 Total revenue...
Lumina Networks Enters SDN Market
Aug 07, 2017 12:00 pm UTC| Business
SAN JOSE, Calif., Aug. 07, 2017 -- Lumina Networks, Inc. launched today in the software-defined networking (SDN) market, through its acquisition of assets associated with the SDN Controller product family from Brocade...
Payment Data Systems Announces Update on the Acquisition of Singular Payments, LLC
Aug 07, 2017 12:00 pm UTC| Business
SAN ANTONIO, Aug. 07, 2017 -- Payment Data Systems, Inc. (NASDAQ:PYDS) (“Payment Data” or “Company”), an integrated electronic payment solutions provider, today announced that it has amended the terms of its non-binding...
Drone Aviation Secures $4 Million in Funding for Increased Sales and Production Capability
Aug 07, 2017 12:00 pm UTC| Business
JACKSONVILLE, FL, Aug. 07, 2017 -- Drone Aviation Holding Corp. (OTCQB: DRNE) (“Drone Aviation” or the “Company”), a manufacturer of tethered drones and lighter-than-air aerostats, today announced that it has secured up...
G.fast Revenue Forecast To Grow Almost 600 Percent in 2019, According to Dell’Oro Group
Aug 07, 2017 12:00 pm UTC| Business
REDWOOD CITY, Calif., Aug. 07, 2017 -- According to a newly published report by Dell’Oro Group, the trusted source for market information about the telecommunications, networks, and data center IT industries, G.fast...
Aug 07, 2017 12:00 pm UTC| Business
LAKEVILLE, Minn., Aug. 07, 2017 -- Lake Marion Chiropractic Center announced that its doctor, Dr. Craig Couillard, was invited to be part of the World Games Sports Medicine Team. The World Games took place in Wroclaw,...
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2017 Financial Results
Aug 07, 2017 12:00 pm UTC| Business
SAN DIEGO, Aug. 07, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders,...